Financial results - NICOMED SRL

Financial Summary - Nicomed Srl
Unique identification code: 8059666
Registration number: J34/542/1995
Nace: 8622
Sales - Ron
601.976
Net Profit - Ron
78.954
Employee
24
The most important financial indicators for the company Nicomed Srl - Unique Identification Number 8059666: sales in 2023 was 601.976 euro, registering a net profit of 78.954 euro and having an average number of 24 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nicomed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 248.368 255.294 308.895 391.736 458.842 474.416 507.898 499.365 501.434 601.976
Total Income - EUR 248.370 257.545 308.897 391.737 459.328 482.795 526.148 499.368 501.438 601.980
Total Expenses - EUR 219.802 258.245 283.066 360.630 393.605 410.574 467.316 472.132 445.453 519.074
Gross Profit/Loss - EUR 28.568 -700 25.831 31.107 65.723 72.221 58.832 27.235 55.985 82.906
Net Profit/Loss - EUR 21.701 -766 21.022 27.140 61.242 67.868 54.027 22.241 51.071 78.954
Employees 19 18 20 22 26 24 23 24 24 24
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 20.4%, from 501.434 euro in the year 2022, to 601.976 euro in 2023. The Net Profit increased by 28.037 euro, from 51.071 euro in 2022, to 78.954 in the last year.

Check the financial reports for the company - Nicomed Srl

Rating financiar

Financial Rating -
Nicomed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Nicomed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nicomed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Nicomed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nicomed Srl - CUI 8059666

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 242.744 227.896 205.080 261.162 244.873 384.425 421.394 327.768 289.517 295.477
Current Assets 8.486 6.363 2.179 2.030 11.194 16.609 19.332 26.162 27.907 31.877
Inventories 0 5.725 10 656 1.174 629 2.213 11.210 13.934 13.182
Receivables 0 0 0 0 2.121 1.131 1.064 3.692 2.441 633
Cash 8.486 638 2.169 1.374 7.899 14.850 16.054 11.260 11.531 18.062
Shareholders Funds 138.293 138.681 158.038 182.504 240.397 276.214 254.289 270.891 251.188 254.205
Social Capital 67 67 67 66 64 63 62 61 61 61
Debts 115.196 96.692 49.542 80.687 15.670 128.648 191.000 85.342 65.421 73.149
Income in Advance 0 0 0 0 0 0 0 0 1.501 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 31.877 euro in 2023 which includes Inventories of 13.182 euro, Receivables of 633 euro and cash availability of 18.062 euro.
The company's Equity was valued at 254.205 euro, while total Liabilities amounted to 73.149 euro. Equity increased by 3.778 euro, from 251.188 euro in 2022, to 254.205 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Nicomed Srl

Comments - Nicomed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.